新型冠状病毒疫苗对内分泌系统的影响。
Influence of COVID-19 vaccines on endocrine system.
机构信息
Geriatric Medicine Center, Key Laboratory of Endocrine Gland Diseases of Zhejiang Province, Department of Endocrinology, Zhejiang Provincial People's Hospital, Affiliated People's Hospital, Hangzhou Medical College, Hangzhou, China.
出版信息
Endocrine. 2022 Nov;78(2):241-246. doi: 10.1007/s12020-022-03119-3. Epub 2022 Jun 25.
Abstract
The COVID-19 pandemic has posed a significant health threat globally. Timely and appropriate vaccination is a key step to reduce the morbidity and mortality from COVID-19. The clinical course of COVID-19 infection and the effects of COVID-19 vaccination are influenced by patients' health situations and involve a systemic physiological reaction. Just like an "endocrine phenotype" of COVID-19 infection, endocrine dysfunction after COVID-19 vaccination also acquired clinical concerns. In the present review, we briefly introduce the commonly available vaccines against SARS-CoV-2, summarize the influence of COVID-19 vaccines on the endocrine system, and explore the underlying pathogenic mechanisms.
摘要
新型冠状病毒肺炎（COVID-19）大流行对全球健康构成了重大威胁。及时、恰当的疫苗接种是降低 COVID-19 发病率和死亡率的关键步骤。COVID-19 感染的临床过程和 COVID-19 疫苗的作用受到患者健康状况的影响，并涉及全身生理反应。就像 COVID-19 感染的“内分泌表型”一样，COVID-19 疫苗接种后的内分泌功能障碍也引起了临床关注。在本综述中，我们简要介绍了目前可用的针对严重急性呼吸综合征冠状病毒 2（SARS-CoV-2）的疫苗，总结了 COVID-19 疫苗对内分泌系统的影响，并探讨了潜在的发病机制。
相似文献
1
Influence of COVID-19 vaccines on endocrine system.新型冠状病毒疫苗对内分泌系统的影响。
Endocrine. 2022 Nov;78(2):241-246. doi: 10.1007/s12020-022-03119-3. Epub 2022 Jun 25.
2
COVID-19 vaccines: comparison of biological, pharmacological characteristics and adverse effects of Pfizer/BioNTech and Moderna Vaccines.COVID-19 疫苗：辉瑞/生物科技和 Moderna 疫苗的生物学、药理学特征和不良反应比较。
Eur Rev Med Pharmacol Sci. 2021 Feb;25(3):1663-1669. doi: 10.26355/eurrev_202102_24877.
3
Multiple Sclerosis Disease-Modifying Therapy and the COVID-19 Pandemic: Implications on the Risk of Infection and Future Vaccination.多发性硬化症的疾病修正治疗与 COVID-19 大流行：感染风险和未来疫苗接种的影响。
CNS Drugs. 2020 Sep;34(9):879-896. doi: 10.1007/s40263-020-00756-y.
4
[Vaccination contre le SARS-CoV-2, le Graal ?].[新冠病毒疫苗接种，是万灵药吗？]
Rev Prat. 2022 May;72(5):517-522.
5
SARS-CoV-2 the ASIA virus (Autoimmune/autoinflammatory Syndrome Induced by Adjuvants), the risk of infertility and vaccine hesitancy.SARS-CoV-2 即亚洲病毒（佐剂诱导的自身免疫/炎症综合征），存在不孕和疫苗犹豫的风险。
Expert Rev Vaccines. 2022 Sep;21(9):1177-1184. doi: 10.1080/14760584.2022.2089120. Epub 2022 Jul 1.
6
SARS-CoV-2-related and Covid-19 vaccine-induced thromboembolic events: A comparative review.SARS-CoV-2 相关及新冠病毒疫苗诱导的血栓栓塞事件：比较综述。
Rev Med Virol. 2022 Jul;32(4):e2327. doi: 10.1002/rmv.2327. Epub 2022 Feb 3.
7
[The corona pandemic and multiple sclerosis: vaccinations and their implications for patients-Part 2: vaccine technologies].[新冠疫情与多发性硬化症：疫苗接种及其对患者的影响 - 第2部分：疫苗技术]
Nervenarzt. 2021 Dec;92(12):1283-1292. doi: 10.1007/s00115-021-01154-5. Epub 2021 Jul 7.
8
In Pursuit of a SARS-CoV-2 Vaccine.对新型冠状病毒疫苗的探索
J Foot Ankle Surg. 2020 Nov-Dec;59(6):1133-1134. doi: 10.1053/j.jfas.2020.09.011.
9
A multinational, phase 2, randomised, adaptive protocol to evaluate immunogenicity and reactogenicity of different COVID-19 vaccines in adults ≥75 already vaccinated against SARS-CoV-2 (EU-COVAT-1-AGED): a trial conducted within the VACCELERATE network.一项在已接种 SARS-CoV-2 疫苗的≥75 岁成年人中评估不同 COVID-19 疫苗免疫原性和反应原性的多国、2 期、随机、自适应方案：在 VACCELERATE 网络内开展的一项试验。
Trials. 2022 Oct 8;23(1):865. doi: 10.1186/s13063-022-06791-y.
10
Consensus summary report for CEPI/BC March 12-13, 2020 meeting: Assessment of risk of disease enhancement with COVID-19 vaccines.CEPI/BC 2020 年 3 月 12-13 日会议共识总结报告：评估 COVID-19 疫苗引起疾病增强的风险。
Vaccine. 2020 Jun 26;38(31):4783-4791. doi: 10.1016/j.vaccine.2020.05.064. Epub 2020 May 25.
引用本文的文献
1
Fatal pneumonia in a patient with Kearns-Sayre syndrome case report and literature review.1例患有卡恩斯-塞尔综合征患者的致命性肺炎：病例报告及文献综述
Front Med (Lausanne). 2025 Jul 31;12:1575384. doi: 10.3389/fmed.2025.1575384. eCollection 2025.
2
Endocrine dysregulation in COVID-19: molecular mechanisms and insights.新型冠状病毒肺炎中的内分泌失调：分子机制与研究进展。
Front Endocrinol (Lausanne). 2024 Oct 22;15:1459724. doi: 10.3389/fendo.2024.1459724. eCollection 2024.
3
Type 1 Diabetes Mellitus Caused by COVID-19 mRNA Vaccination: A Case Report and Literature Review of 17 Published Cases.新冠病毒mRNA疫苗引发的1型糖尿病：一例病例报告及对17例已发表病例的文献综述
AACE Clin Case Rep. 2024 Jun 13;10(5):179-183. doi: 10.1016/j.aace.2024.06.001. eCollection 2024 Sep-Oct.
4
COVID-19 Vaccines: A Radiological Review of the Good, the Bad, and the Ugly.COVID-19疫苗：关于其益处、弊端及不良影响的影像学综述
Indian J Radiol Imaging. 2024 Apr 21;34(4):714-725. doi: 10.1055/s-0044-1785210. eCollection 2024 Oct.
5
Arginine vasopressin deficiency onset after COVID-19 vaccination with positive anti-rabphilin-3A antibodies: a case report and literature review.新冠肺炎疫苗接种后出现精氨酸加压素缺乏症伴抗 Rabphilin-3A 抗体阳性：病例报告及文献复习。
BMC Endocr Disord. 2024 Aug 6;24(1):143. doi: 10.1186/s12902-024-01664-8.
6
SARS-CoV-2-Vaccine-Related Endocrine Disorders: An Updated Narrative Review.严重急性呼吸综合征冠状病毒2型疫苗相关内分泌疾病：最新叙述性综述
Vaccines (Basel). 2024 Jul 8;12(7):750. doi: 10.3390/vaccines12070750.
7
COVID-19 vaccines and blood glucose control: Friend or foe?COVID-19 疫苗与血糖控制：敌是友非？
Hum Vaccin Immunother. 2024 Dec 31;20(1):2363068. doi: 10.1080/21645515.2024.2363068. Epub 2024 Jun 11.
8
Transient Central Diabetes Insipidus (Arginine Vasopressin Deficiency) Following SARS-CoV-2 Vaccination: A Case Report and Literature Review.接种 SARS-CoV-2 疫苗后一过性中枢性尿崩症（精氨酸血管加压素缺乏症）：病例报告及文献复习。
Endocr Metab Immune Disord Drug Targets. 2024;24(15):1856-1864. doi: 10.2174/0118715303286560231124115052.
9
COVID-19 Vaccine-Induced Expansion of Pituitary Adenoma: A Case Report.新冠病毒疫苗诱导垂体腺瘤增大：一例报告
Cureus. 2023 Dec 17;15(12):e50685. doi: 10.7759/cureus.50685. eCollection 2023 Dec.
10
Endocrine diseases associated with COVID-19 vaccination: case report.与 COVID-19 疫苗接种相关的内分泌疾病：病例报告。
Rev Peru Med Exp Salud Publica. 2023 Jul-Sep;40(3):364-368. doi: 10.17843/rpmesp.2023.403.12572. Epub 2023 Sep 28.
本文引用的文献
1
Understanding Vaccine Safety and the Roles of the FDA and the CDC.了解疫苗安全性以及美国食品药品监督管理局（FDA）和疾病控制与预防中心（CDC）的职责。
N Engl J Med. 2022 Apr 28;386(17):1638-1645. doi: 10.1056/NEJMra2200583.
2
Relapsed and newly diagnosed Graves' disease due to immunization against COVID-19: A case series and review of the literature.因接种 COVID-19 疫苗导致的复发性和新诊断的 Graves 病：病例系列和文献复习。
J Autoimmun. 2022 Apr;128:102809. doi: 10.1016/j.jaut.2022.102809. Epub 2022 Feb 24.
3
SARS-CoV-2: Emerging Role in the Pathogenesis of Various Thyroid Diseases.严重急性呼吸综合征冠状病毒2（SARS-CoV-2）：在各种甲状腺疾病发病机制中的新作用
J Inflamm Res. 2021 Nov 24;14:6191-6221. doi: 10.2147/JIR.S332705. eCollection 2021.
4
Multisystem Inflammatory Syndrome in an Adult after COVID-19 Vaccination: a Case Report and Literature Review.成人接种新冠疫苗后出现多系统炎症综合征：病例报告和文献复习。
J Korean Med Sci. 2021 Nov 22;36(45):e312. doi: 10.3346/jkms.2021.36.e312.
5
COVID-19: Pulmonary and Extra Pulmonary Manifestations.新型冠状病毒肺炎：肺及肺外表现。
Front Public Health. 2021 Sep 28;9:711616. doi: 10.3389/fpubh.2021.711616. eCollection 2021.
6
Graves' disease following SARS-CoV-2 vaccination.新型冠状病毒疫苗接种后发生的格雷夫斯病。
Endocrine. 2021 Dec;74(3):473-474. doi: 10.1007/s12020-021-02902-y. Epub 2021 Oct 14.
7
Thyrotoxicosis after COVID-19 vaccination: seven case reports and a literature review.新冠疫苗接种后发生的甲状腺毒症：7例病例报告及文献综述
Endocrine. 2021 Dec;74(3):470-472. doi: 10.1007/s12020-021-02898-5. Epub 2021 Oct 12.
8
Hyperglycemic Emergencies Associated With COVID-19 Vaccination: A Case Series and Discussion.与新冠病毒疫苗接种相关的高血糖急症：病例系列及讨论
J Endocr Soc. 2021 Sep 25;5(11):bvab141. doi: 10.1210/jendso/bvab141. eCollection 2021 Nov 1.
9
A Case of Hypophysitis Following Immunization With the mRNA-1273 SARS-CoV-2 Vaccine.接种 mRNA-1273 型 SARS-CoV-2 疫苗后发生的垂体炎病例报告。
J Investig Med High Impact Case Rep. 2021 Jan-Dec;9:23247096211043386. doi: 10.1177/23247096211043386.
10
Aggravation of hyperthyroidism after heterologous prime-boost immunization with inactivated and adenovirus-vectored SARS-CoV-2 vaccine in a patient with Graves' disease.1例格雷夫斯病患者在接受灭活和腺病毒载体新冠病毒疫苗的异源初免-加强免疫后甲亢加重
Endocrine. 2021 Nov;74(2):226-227. doi: 10.1007/s12020-021-02879-8. Epub 2021 Sep 17.
Zotero 插件